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The morphological appearance and some ingredients of Panax ginseng, Panax notoginseng and 
Panax japonicus of the Panax genus are similar. However, their pharmacological activities are 
obviously different due to the significant differences in the types and quantity of saponins in 
each herb. In the present study, ultra-performance liquid chromatography-quadrupole time-of-
flight mass spectrometry (UPLC-QTOFMS) was used to profile the abundances of metabolites in 
the three medicinal Panax herbs. Multivariate statistical analysis technique, that is, principle 
component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were used 
to discriminate between the Panax samples. PCA of the analytical data showed a clear separation 
of compositions among the three medicinal herbs. The critical markers such as 
chikusetsusaponin IVa, ginsenoside R0, ginsenoside Rc, ginsenoside Rb1, ginsenoside Rb2 and 
ginsenoside Rg2 accountable for such variations were identified through the corresponding 
loading weights, and the tentative identification of biomarkers is completed by the accurate mass 
of TOFMS and high resolution and high retention time reproducibility performed by UPLC. The 
proposed analytical method coupled with multivariate statistical analysis is reliable to analyze a 
group of metabolites present in the herbal extracts and other natural products. This method can 
be further utilized to evaluate chemical components obtained from different plants and/or the 
plants of different geographical locations, thereby classifying the medicinal plant resources and 




It is estimated that about 65–80% of the world’s population is using traditional medicine as the 
primary form of healthcare (Akerele 1992). Traditional Chinese medicines (TCMs) are gaining 
more and more attention in many fields because of their low toxicity and good therapeutic 
performance. The quality and contents of herbs are highly variable depending on geographical 
origins, climate, cultivation, and the growth stage when harvested (Mahady et al. 2001). The 
profiling of natural products requires an analytical system capable of generating an information 
rich data set and needs to identify the compounds of interest, compare different batches of 
material to be compared and contrasted and isolate the compounds of interest from bulk solution. 
However, because of the chemical diversity of the metabolome, which for any given 
multicellular species comprises a mixture of thousands of compounds differing in size, polarity 
etc., and varying in abundance by several orders of magnitude, the need for multiparallel 
analytical techniques is obvious and well-accepted (Goodacre et al. 2004; Hall 2006). A number 
of techniques including nuclear magnetic resonance (NMR), liquid chromatography (LC) or gas 
chromatography (GC) coupled with mass spectrometry (MS) have been employed for metabolite 
profiling (Fiehn et al. 2000; Want et al. 2005; Fukusaki et al. 2006; Nordstrom et al. 2006; 
Wagner et al. 2006; Farag et al. 2007). While the NMR metabolite profiling approach provides 
the valuable metabolite signature of a complex sample, LC-MS has higher sensitivity, resolution 
and resolves individual chemical components into separate peaks, enhancing the opportunity to 
mine and uncover novel metabolites (Chan et al. 2007). Unlike GC-MS, LC-MS is in principle a 
more versatile analytical tool. It covers a much wider mass range and allows one to target many 
compound classes not detectable by GC-MS. Furthermore, there is usually no need for 
complicated derivatization, and modern LC-MS setups offer superior options to structurally 
elucidate unknown metabolites, namely, accurate mass determination and elemental composition 
analysis. Among the various LC platforms, the soaring development of column particle materials 
has highlighted a new addition to chromatographic separation technology, the ultra-performance 
liquid chromatography (UPLC), which allows satisfactory separation, good resolution and 
sensitivity, and high-speed detection (Shen et al. 2005; Wilson et al. 2005; Nordstrom et al. 
2006) with complex biological samples, such as herbal medicine (Guan et al. 2007). Coupled to 
quadrupole time-of-flight mass spectrometry (QTOFMS), UPLC/QTOFMS was used to achieve 
comprehensive and reliable metabolite profiling (Nordstrom et al. 2006) and recently the UPLC 
coupled with MS has been used for metabolite profiling in herbal medicine successfully both by 
other researchers and our group (Chan et al. 2007; Xie et al. 2008).  
 
Panax ginseng, Panax notoginseng and Panax japonicus are all highly valuable and important 
tonic herbs belonging to Panax genus cultivated in different locations in China. While the P. 
ginseng, mainly cultivated in northeastern China, Jilin, for example, is used in traditional 
Chinese medicine (TCM) to enhance stamina and capacity coping with fatigue and physical 
stress. Brekhman, a pioneer in the experimental evaluation of ginseng, used the term adaptogen 
to describe these non-specific “tonic” effects of P. ginseng and other members of the Ariliaceae 
family (Brekhman and Dardymov 1969), in contrast, P. notoginseng is mainly cultivated in 
southwestern China (e.g. Yunnan Province of China) and used in TCM for its haemostatic and 
cardiovascular properties (National Committee of Pharmacopoeia 2005). P. japonicus, mainly 
distributed in west China, has effect of protecting on the cardiovascular system, enhancing the 
immune system, antiviral, relieving swelling and alleviating pain (Jiangsu New Medical College 
1985). However, their traditional indications are significantly different although the three Panax 
samples all contains ginsenosides (saponins) which are usually considered to be the major active 
components and the types and quantity of saponins in each herb were significantly different. The 
level of total saponins of P. japonicus was higher than that of P. ginseng and P. notoginseng and 
in which oleanane saponins are the main active constituents (Zuo and Yuan 2005). There are 
dammarane-type and oleanane-type saponins in both P. ginseng and P. japonicus, but the latter 
saponins are absent in P. notoginseng (Wei et al. 1991). The content of dammarane-type 
saponins in P. ginseng was higher than in P. japonicus whereas the content of oleanane saponins 
was lower in P. japonicus (Guo et al. 2004). These saponins are accountable for diverse 
therapeutic effects, thus understanding of the bio-distribution of these secondary metabolites in 
different type of Panax plants is paramount for the investigation of their pharmacological 
efficiency (Wang et al. 2005) and therefore, chemical characteristics are very important for the 
identification and quality control of the three herbs. The metabolite profiling of Panax herbs 
including Chinese ginseng, American ginseng and Korean ginseng has been carried out 
successfully with the developed UPLC-TOFMS method and multivariate statistical analysis (Xie 
et al. 2008). From the result we can see that ginseng samples from different locations in China 
and outside China (including Chinese, American and Korean) were different and can be 
separated with the developed method. So in this study we want to know whether the ginseng 
samples cultivated in different locations of China is different and can be separated with the 
developed method or not, and identify the differentiate saponins accountable for such variations.  
 
Metabolomics, aims to identify and quantify the full complement of low-molecular-weight, 
soluble metabolites in actively metabolizing tissues (Oliver et al. 1998; Fiehn 2002; Fiehn and 
Weckwerth 2003; Rochfort 2005), has aroused extensive awareness and interests, especially in 
the botanical studies such as quality control of plants (Huhman and Sumner 2002; Chang et al. 
2006; Holmes 2006; Eisenreich 2007; Tarachiwin et al. 2007) and plant engineering (Anterola 
and Lewis 2002; Long et al. 2006). Several methods have been developed for the analysis and 
differentiation of Panax samples, but the number and type of saponins detected was relatively 
low. Moreover, the comparison of among the three Panax herbs including P. notoginseng, P. 
ginseng and P. japonicus in detail has been not reported. Comprehensive metabolite profiling of 
these extracts will provide greater information to elucidate the holistic therapeutic effects of P. 
notoginseng as well as P. ginseng and P. japonicus when used as TCMs. In this study, an UPLC-
QTOFMS-based analytical method was developed in the analysis of three Panax samples and a 
metabolite profiling of three Panax herbs was performed utilizing an UPLC-QTOFMS analytical 
method in association with multivariate statistical analysis, not as a form of quality control, but 
as a tool for the identification of the variations in bioactive components among different Panax 
herbs.  
 
MATERIALS AND METHODS 
Chemicals and materials  
Leucine-enkephalin and formic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Acetonitrile and methanol of HPLC grade were obtained from Merck, Germany. Analytical-
grade methanol was obtained from Shanghai Lin Feng chemical reagent Co., Ltd., P. R. China. 
All aqueous solutions were prepared with ultrapure water produced by Milli-Q system (18.2 MΩ, 
Milipore, Bedford, MA, USA). Notoginsenoside R1, ginsenoside Rb1, Rg1 and Re standards 
were purchased from the National Institute for the Pharmaceutical and Biological Products 
(Beijing, P. R. China). Ginsenoside Rb2, Rb3, Rc, Rd and F2 standards were obtained from 
Sanqi Research Institute of Wenshan Prefecture (Wenshan, Yunnan Province, P. R. China). 
Notoginsenoside R2, ginsenoside Rh2, 20(R)-Rg3, Rg2, and F1 were obtained from Wuhu 
DELTA Co. Ltd (Wuhu, Anhui Province, P. R. China). The chemical structures of the 
investigated saponins are shown in Table 1. Eleven Panax notoginseng samples cultivated for 
3 years were collected locally from three villages (Xinkaitian, Kanxin and Leshichong) of 
Wenshan Prefecture, Yunnan Province, P. R. China. Eleven authentic root samples of Panax 
ginseng were collected locally from eleven places (Tonghua, Changbai, Huadian, Jian, 
Songjianghe, Dunhua, Jingyu, Lushuihe, Fusong, Linjiang and Baishan) of Jinlin Province, 
China and one from Shanghai Hua Yu herbs Co., Ltd, Shanghai, China. Panax japonicus were 
collected from Hubei, Sichuan and Shanxi provinces of China, respectively. They all were 
identified as the genuine root samples of Panax notoginseng (Burk.) F. H. Chen, Panax ginseng 
and Panax japonicus by Zhongliu, Prof. of pharmacognostics, School of Pharmacy, Shanghai 
Jiao Tong University of China, respectively.  
 
Table 1: Structures of investigated saponins (Glc, β-D-glucose; Rha, α-L-rhamnose; Ara(p), α-L-
arabinose (pyranose); Ara(f), α-L-arabinose (furanose); Xyl, β-D-xylose; glcU: β-D-glucuronic 
acid)  
Chemical structures Saponins R1 R2 
 
Ginsenoside Rb1 –Glc2–Glc  –Glc6–Glc  
Ginsenoside Rb2 –Glc2–Glc  –Glc6–Ara(p)  
Ginsenoside Rc –Glc2–Glc  –Glc6–Ara(f)  
Ginsenoside Rd –Glc2–Glc  –Glc 
Ginsenoside F2 –Glc –Glc 
Ginsenoside Ra3 –Glc2–Glc  –Glc6–Glc  
Ginsenoside Rh2 –Glc –H 
Protopanaxadiol –H –H 
Notoginsenoside R4 –Glc2–Glc  –Glc6–Glc6–Xyl  
Notoginsenoside Fa –Glc2–Glc2–Xyl  –Glc6–Glc  
Chikusetsusaponin III –Glc2–Glc6–Xyl  –H 
 
Notoginsenoside R1 –Glc2–Xyl  –Glc 
Ginsenoside Rg1 –Glc –Glc 
Ginsenoside Rg2  –Glc2–Rha  –H 
Ginsenoside Re –Glc2–Rha  –Glc 
Ginsenoside Rf –Glc2–Glc  –Glc 
 
Ginsenoside R0 –GlcU2–Glc  –Glc 
Chikusetsusaponin IV –GlcU4–Araf  –Glc 
Chikusetsusaponin Ib –GlcU –Glc 
Chikusetsusaponin IVa –GlcU4–Ara(f)6–Glc  –H 
 
Ginsenoside Rh4 –H –Glc 
 
Ginsenoside II –Glc2–Glc  –Glc 
 
 
Sample preparation  
A standard mixture containing, ginsenoside Rb1, Rg1, Re, Rb2, Rb3, Rc, Rd, F2, Rh2, 20(R)-
Rg3, Rg2, F1 and notoginsenoside R1, R2 was prepared in 70% (v/v) methanol. A volume of 
2 μl of a standard mixture was used during UPLC/TOFMS method development and validation 
of retention time reproducibility and mass accuracy. The original root samples were pulverized 
with a pulverizer, and the powder was sieved through 180 μm sieves. The obtained fine powder 
(2 g) was weighed, and 20 ml of 70% (v/v) methanol were added. The powder was then 
extracted in an ultrasonic water bath at 50 °C for 60 min (Gao et al. 2008). The extraction was 
repeated three times. After cooling, the solution was filtered and concentrated till dryness in 
vacuo; the residue was dissolved through adding little volume of 70% (v/v) methanol in 
succession by ultrasonication till the residue was entirely dissolved and transferred to a 50 ml 
volumetric flask and 70% methanol was added to scale. The fluid was filtered through a syringe 
filter (0.22 μm) and injected directly into the UPLC system. Blank 70% (v/v) methanol (2 μl) 
was injected between selected analyses to validate inter-sample cross talking effect.  
 
UPLC-QTOFMS analysis  
Panax herbs metabolite profiling was performed using a Waters ACQUITY UPLC™ system 
(Waters Corporation, Milford, MA, USA) which was equipped with a binary solvent delivery 
manager, and a sample manger coupled to Micromass Q-TOF Premier™ mass spectrometer 
(Waters Corporation, Milford, MA, USA) equipped with an electrospray interface. 
Chromatographic separations were performed on a 2.1 × 100 mm 1.7 μm ACQUITY BEH C18 
chromatography column. The column was maintained at 40°C and eluted with a gradient of 10–
90% acetonitrile (0.05% (v/v) formic acid)-aqueous formic acid (0.05% (v/v) formic acid) over 
20 min at a flow rate of 0.35 ml/min. A 10 μl injection of this sample was made onto the column.  
 
A metabonomics MS System Test Mixture including acetaminophen, tolbutamide, 3′-azido-3′-
deoxythymidine, reserpine, verapamil and coumarin was used as chromatographic reference and 
mass accuracy quality control. This test mixture was injected every ten injections. The mass 
spectrometer was operated in positive ion mode. The desolvation temperature was set to 400°C 
at a flow rate of 700 l/h and source temperature of 100°C. The capillary and cone voltages were 
set to 3500 and 45 V, respectively. The data was collected between 400 and 1,500 m/z with an 
alternating collision energy, at 5 eV for precursor ion information generation and a collision 
profile from 10 to 40 eV for fragment ion information. The Q-TOF premier™ was operated in v 
mode with 10,000 mass resolving power. Data were centroided during acquisition using 
independent reference lock-mass ions via the LockSprayTM interface to ensure mass accuracy 
and reproducibility. Leucine-enkephalin was used as the reference compound at a concentration 
of 50 pg/μl and an infusion flow rate of 0.05 ml/min. The LocksprayTM was operated at a 
reference scan frequency of 10 or analyte to reference scan ratio of 9:1 and a reference cone 
voltage of 45 V. For ES+, isotopic [M+H]+ ions of leucine-enkephalin at 556.2771 Da and 
557.2804 Da were used as the attenuated lock mass and lock mass, respectively. During 
metabolite profiling experiments, centroided data were acquired for each sample from 400 to 
1,500 Da with a 0.10 s scan time and a 0.01 s interscan delay over a 20 min analysis time.  
 
Chemometric data analysis  
The UPLC-QTOFMS data of P. ginseng, P. japonicus and P. notoginseng samples were 
analyzed to identify potential discriminant variables. The ES+ raw data were analyzed by the 
MarkerLynx applications manager version 4.1 (Waters, Manchester, UK). The parameters used 
were RT range 0–20 min, mass range 400–1,500 Da, mass tolerance 0.02 Da, isotopic peaks 
were excluded for analysis, noise elimination level was set at 10.00, minimum intensity was set 
to 10% of base peak intensity, maximum masses per RT was set at 6 and, finally, RT tolerance 
was set at 0.01 min. After creating a suitable processing method, the next step is to process the 
dataset through the Create Dataset window. Selecting the method we just created and creating 
our dataset, we would like to (a) Detect Peaks, (b) Collect Markers, and (c) perform PCA. Select 
all of these options from the Processing Options panel of the Create DataSet display and at this 
point it is also possible to automatically Print Reports and Export data into a text file for use in 
third party software such as Pirouette and SIMCA-P. After data processing, a list of the 
intensities of the peaks detected was generated for the first sample, using retention time (RT) and 
m/z data pairs as the identifier of each peak. The resulting two-dimensional matrix of measured 
mass values and their intensity for each sample were further exported to SIMCA-P software 11.0 
(Umetrics, Umeå, Sweden) for multivariate statistical analysis. Multivariate statistical analysis, 
including unsupervised principal component analysis (PCA) and supervised partial least squares-
discriminant analysis (PLS-DA), were performed by SIMCA-P 11.0 software (Umetrics, Umeå, 
Sweden). The data sets were mean-centered, pareto-scaled in a columnwise manner before PCA 
and PLS-DA modeling. Mean centering subtracts the average from the data sets columnwise, 
thereafter resulting in a shift of the data towards the mean. Pareto scaling gives each variable a 
variance equal to the square root of its standard deviation. As compared to UV-scaling (scaling 
to unit variance) method, the advantage of using this technique lies in the fact that it enhances the 
contribution of lower concentration metabolites without amplifying noise and artifacts 
commonly present in the metabonomic data sets (Cloarec 2005). PCA was universally used for 
achieving the natural interrelationship including grouping, clustering, and outliers among 
observations without priori knowledge of the data set. The first principal component (PC1) 
contains the most variance in the data set. The second principal component, (PC2), is orthogonal 
to PC1, and represents maximum amount of variance not explained by PC1. The remaining 
components are attained in a similar manner, thereby reducing the high dimensional data sets to a 
two- or three-dimensional scores map without losing profound information.  
 
Additionally, in order to maximize the variations among the Panax species, sophisticated 
supervised methods including PLS-DA was further applied. PLS-DA is a modification of PLS 
targeting classification and discrimination problems by pre-defining the dummy Y as a specific 
descriptor (e.g. 0/1). PLS is a generalized multiple regression method that can deal with multiple 
collinear X and Y variables and has two objectives: one is to well approximate X and Y, and the 
other is to model the relationship between them. R2X and R2Y represent the fraction of the 
variance of X matrix and Y matrix, respectively, while Q2Y suggests the predictive accuracy of 
the model. The cumulative values of R2X, R2Y and Q2Y close to 1 indicate an excellent model. 
Variable influence on projection (VIP) values greater than 1.0 are considered statistically 
significant for group discrimination. In SIMCA-P package, a typical cross-validation procedure 
was conducted by leaving 1/7th samples out in each round so as to validate the PLS-DA model 
against over-fitting. In order to compare the combined MS dataset from P. notoginseng to P. 
ginseng and from P. japonicus to P. ginseng, on a basis of the threshold of p values and fold 
change values from nonparametric Wilcoxon–Mann–Whitney test implemented in the Matlab 
statistical toolbox, the differential metabolites derived from the correlation coefficients (Cloarec 
2005) of a cross-validated PLS-DA model were validated at a univariate level.  
 
RESULTS AND DISCUSSION 
UPLC method development  
The UPLC system provided a rapid, effective, and convenient analytical method for the detection 
of a wide range of saponins present in the three Panax herbs. The major benefit expected from 
the use of the sub-2 μm particles is the increased column efficiency and concomitant increased 
resolution. Under the optimum UPLC conditions mentioned in our previous work (Xie et al. 
2008), the BPI (Based Peak Intensity) chromatogram obtained from the analysis of P. ginseng in 
positive ion mode is shown in Fig. 1. The peak widths generated were on the order of 10 s at the 
base, giving a separation peak capacity of 130 for a 20 min separation or approximately 6 peaks 
per min. Furthermore, a 2D map plot of UPLC chromatogram from the three Panax herbs clearly 
shows that hundreds of peaks were detected by the UPLC system over the m/z scan range 400–
1,500 within 20 min (Fig. 2). Based on the optimum UPLC conditions, the reproducibility of the 
data was studied also and the retention time variability was determined to be 0.01 s or with a 
relative standard deviation (RSD) value less than 0.1%. From the result we can see that the 
retention time reproducibility of the system was excellent.  
 
Figure 1: UPLC-TOFMS ES+ base peak intensity (BPI) chromatogram of P. ginseng (20 min separation on a 
2.1 × 100 mm 1.7 μm ACQUITY BEH C18 UPLC column)  
 
 
Figure 2: Map plot of positive ion UPLC-TOFMS analysis of three Panax extracts including P. notoginseng (a), P. 
Japonicus (b), and P. ginseng (c)  
 
 
To illustrate the ability of the UPLC chromatography system to distinguish between the different 
Panax herbs, P. notoginseng (A), P. japonicus (B) and P. ginseng (C) were analyzed by the same 
methodology, the results are displayed in Fig. 3 and there is a definite difference between the 




Figure 3: Comparison of UPLC chromatograms for three Panax extracts including P. notoginseng (a), P. Japonicus 
(b), and P. ginseng (c)  
 
 
Mass detection conditions  
More information on saponins was obtained in the ES+ mode than ES− mode due to higher 
degree of ion fragmentation as revealed by the representative total ion current (TIC) spectra on 
the UPLC-TOFMS. The mass detection conditions were optimized according to our previous 
work (Xie et al. 2008). The precision and reproducibility of peak integration was good for the 
final results and the ability to collect the MS and MS/MS data in one analytical run was clearly 
demonstrated (Kevin et al. 2007) and the sampling rate is sufficient to provide an accurate 
representation of the chromatographic separation.  
 
The accurate mass measurement and MS/MS analysis of saponins in this study was performed at 
different collision energies ranging from 5 to 40 eV with MSE (E represents low-high collision 
energy) approach (Xie et al. 2008) in order to provide sufficient information necessary to 
distinguish saponins with the same molecular weight, accurate MS and available standards were 
used to verify these important marker ions. Mass measurement of the TOF mass spectrometer 
(Chan et al. 2007) with a group of known low-molecule-weight (between 100 and 1,500 m/z) 
compounds was determined according to our previous work (Xie et al. 2008). The average mass 
accuracy was determined to be 1.14 ppm and from this data, using the MS/MS mode, the exact 
mass of a molecule can be obtained so as to be able to acquire a relevant identification. At the 
same time, accurate mass measurement was rendered by the simultaneous but independent 
acquisition of reference ions of leucine–enkephalin via the LockSpray interface to ensure the 
mass accuracy and through this, problems associated with post column addition of a reference 
compound such as ion suppression due to reference ions, reference ionization efficiency and 
mass interference were avoided.  
 
Principal component analysis  
A two-component PCA score plot of UPLC-QTOFMS data was utilized to depict general 
variation of saponins among the three types of Panax samples (Fig. 4a). According to the data 
pre-treat methods used in our previous work (Xie et al. 2008), clear separation in the PCA space 
of the UPLC-TOFMS analysed Panax samples from the three groups (Fig. 4) was illustrated. 
Visual examination of the chromatograms of UPLC-TOFMS displayed clear difference between 
groups. The clear separation of the three different herbs was observed in the PCA scores plot 
where each coordinate represents a sample (Fig. 4). Two-component PCA model cumulatively 
accounted for 47.7% of variation. The PCA scores plot in Fig. 4(a) could be readily divided into 
three big clusters: one P. notoginseng, the other P. ginseng, and the third P. japonicus, 
confirming that the P. ginseng, P. japonicus and P. notoginseng were different in the levels and 
occurrence of ginsenosides. Each sample was represented as a point in a scores plot (Panax 
japonicus = □, Panax ginseng = ○, and Panax notoginseng = ◊). The P. japonicus and the others 
were clearly separated by the principal component 1 (PC1), whereas the P. ginseng was easily 
discriminated by the principal component 2 (PC2) with the others. In this work, therefore, PCA 
scores plot and loadings plot were achieved using mean-centered, Par-scaled data. Additionally, 
a two-component PLS-DA model (Fig. 4b) (R2X = 0.466, R2Y = 0.922, Q2Y = 0.914) was 
subsequently constructed to identify and reveal the differential metabolites in response to the 
different Panax herbs, which were partially validated with the putative standards. The 
preferential distribution of marker ions in the second quadrant of the loadings plot accounted 
primarily for the difference of P. ginseng. Analogously, the distribution in the third and fourth 
quadrants of the loadings plot indicated the variation of P. notoginseng and P. japonicus, 
respectively.  
 
Figure 4: (a) PCA scores plot, (b) PLS-DA scores plot of (Panax japonicus = □, Panax ginseng = ○, and Panax 
notoginseng = ◊) and (c) PLS-DA loadings plot obtained using Pareto scaling with mean centering  
 
The loadings plot, as presented in Fig. 4c, was obtained using Par scaling with mean-centering. 
Although some information of low intensity might be lost due to Par scaling, the loadings plot 
clearly facilitated the profiling of the marker ions in our experiments. The variation in PC2 in the 
loadings plot was due to the marker ions that accounted for the differences between the P. 
ginseng and the others as observed in the scores plot. These spectral variables were further 
confirmed using the ion intensity plot. The ion intensity plot (Fig. 5) obtained within 
MarkerLynx or SIMCA P 11.0 software was found to be a convenient instrument to aid the 
profiling of marker ions. The representative ion intensity plot (Fig. 5) illustrated the abundance 
of marker ions ginsenoside Rc at m/z 1079.6008 (RT 9.19 min), ginsenoside Rb1 at m/z 
1109.6108 ([M + H]+, Rt 6.82 min), and chikusetsusaponin IVa at m/z 795.4532 ([M+H]+, Rt 
7.90 min) over 54 samples. The ions fulfilled the criteria of marker ions because they were found 
only to be present or have higher level in one herb but not the others. Furthermore, variables with 
high relevance for explaining the differences of the three Panax samples were also identified 
from VIP (variable importance in the projection) values. Large VIP values, more than 1.0, are 
the most relevant for explaining the differences of the three Panax samples. Chikusetsusaponin 
IVa, ginsenoside R0, ginsenoside Rc, ginsenoside Rb1, ginsenoside Rb2 and ginsenoside Rg2 
were found to be significant in creating a differentiation model for the three Panax herbs. Among 
the critical metabolites, chikusetsusaponin IVa and ginsenoside R0 are the active saponins of P. 
japonicus and has the effect of inhibiting the activity of cyclic AMP phos-phodiesterase (Guo 
et al. 2004), ginsenoside Rc and Rb2 have the calcium channel blockade and anti-free-radical 
actions (Zhong et al. 1995).  
 
Tentative peak assignment  
It is possible to determine the importance of variables by analyzing the correlation between 
variables in the PC1 and PC2 dimension; a list of marker ions (metabolites) of interest was 
therefore obtained from the PLS-DA loadings weight (Fig. 4). The experimentally determined 
m/z of the selected marker ion was used to compute the possible calculated mass, mass accuracy 
(mDa and ppm), double-bond equivalent (DBE, total number of rings and double bonds in a 
molecule), empirical formula, and i-Fit value (the likelihood that the isotopic pattern of the 
elemental composition matches a cluster of peaks in the spectrum) and up to 50 best isotopic 
matches for each mass of the potential candidate ions with elemental composition analysis. The 
potential calculated masses, mass accuracy, DBE, i-FIT value and elemental compositions 
associated with the measured mass of the marker ion were generated and studied with 
MarkerLynx. Using the potential marker ion in Fig. 4 as an example, the measured mass of the 
ion was determined to be 795.4532 Da (chikusetsusaponin IVa) and its isotopic pattern indicated 
it as a singly charged ion. Using a mass tolerance of 100 mDa or 10 ppm, four possible 
candidates were produced with the elemental composition analysis software implemented in the 
MarkerLynx. The calculated masses/mDa/ppm/DBE/i-FIT/formula of the four candidates were 
795.4531/0.1/0.1/9.5/6.7/C42H67O14, 795.4590/-5.8/-7.3/0.5/9.1/C35H71O19, 
795.4472/6.0/7.5/18.5/17.7/C49H63O9 and 795.4566/-3.4/-4.3/31.5/54.7/C60H59O, 
respectively. Taking mass accuracy (mDa and ppm), DBE and i-FIT value into consideration, the 
confidence of the tentative marker assignment to the first candidate was enhanced by the high 
mass accuracy obtained (0.1 mDa or 0.1 ppm), fulfillment of 9 DBE (7 rings and 2 double 
bonds) and low i-FIT value (6.7). Marker ions m/z 795.4532 ([M+H]+, Rt 7.90 min) is far from 
the centre in the fourth quadrant of the PLS-DA loadings plot, suggesting that the compound  
 
Figure 5: Representative ion intensity plot for marker ions ginsenoside Rc at m/z 1079.6008 (RT 9.19 min) (a), 
ginsenoside Rb1 at m/z 1109.6108 ([M+H]+, Rt 6.82 min) (b), and chikusetsusaponin IVa at m/z 795.4532 
([M+H]+, Rt 7.90 min) (c) over 54 samples  
 
exhibits a higher importance in P. japonicus than that in the other two herbs. This marker was 
tentatively identified as chikusetsusaponin IVa and this was the characteristic saponin of P. 
japonicus. Marker ions 1109.6108 ([M+H]+, Rt 6.82 min), 621.4328 ([M+H]+, Rt 3.02 min), 
1241.6522 ([M+H]+, Rt 4.90 min), and 785.5065 ([M+H]+, Rt 6.82 min) mainly present in the 
third quadrant are to characterize the P. notoginseng. Marker ions 1079.6008 ([M+H]+, Rt 
9.19 min) mainly present in the second quadrant are to characterize the P. ginseng. In order to 
identify these important marker ions tentatively, qualitative analysis of saponins present in the 
Panax samples was carried out on UPLC-MS/MS system. Saponins were verified by comparing 
the major fragment ions, retention time and accurate mass of marker ions with those of available 
standards. A total of eleven saponins were verified in P. ginseng, eight in P. notoginseng and 
sixteen in P. japonicus using this method (Table 2). Fold changes in relative concentration of 
each saponin of interest were determined for the three Panax herbs and the corresponding heat 
map plot was illustrated to envisage such alterations between groups (Fig. 6). From the figure we 
can see that some saponins such as ginsenoside Rb1 in P. notoginseng was higher than in P. 
ginseng, while in P. japonicus was lower than in P. ginseng and this was consistent with the 
results obtained from the loadings plot.  
 
 
Table 2: Saponins observed in Panax samples of P. ginseng, P. notoginseng and P. japonicus  






Exact mass Mass error (ppm) 
P. ginseng  1 7.85 Ginsenoside Rb2 C53H91O22 1079.6056 1079.6002 5.0 
2 9.19 Ginsenoside Rc C53H91 O22 1079.6008 1079.6002 0.6 
3 6.82 Ginsenoside Rb1 C54H93O23 1109.6099 1109.6108 −0.8 
4 2.98 Ginsenoside Re C48H83O18 947.5574 947.5579 −0.5 
5 13.15 Ginsenoside Rd C48H83O18 947.5532 947.5579 −5.0 
6 6.82 Ginsenoside Rg2 C42H73O13 785.5089 785.5051 4.8 
7 3.02 Ginsenoside Rg1 C42H73O14 801.5048 801.5000 6.0 
8 5.32 Ginsenoside Rf C42H73O14 801.5015 801.5000 1.9 
9 4.94 Ginsenoside Ra3 C59H101O27 1241.6577 1241.6530 3.8 
10 7.94 Ginsenoside II C48H83O20 979.5470 979.5478 −0.8 
11 3.02 Ginsenoside Rh4 C36H61O8 621.4353 621.4366 −2.1 
P. notoginseng  1 2.83 Notoginsenoside R1 C47H81O18 933.5424 933.5423 0.1 
2 6.82 Ginsenoside Rg2 C42H73O13 785.5056 785.5051 0.6 
3 13.19 Ginsenoside Rd C48H83O18 947.5560 947.5579 −2.0 
4 6.82 Ginsenoside Rb1 C54H93O23 1109.6096 1109.6108 −1.1 
5 4.90 Notoginsenoside R4 C59H101O27 1241.6539 1241.6530 0.7 
6 5.70 Notoginsenoside Fa C59H101O27 1241.6450 1241.6530 −6.4 
7 5.41 Ginsenoside Rf C42H73O14 801.5009 801.5000 1.1 
8 3.02 Ginsenoside Rg1 C42H73O14 801.5026 801.5000 3.2 
P. japonicus  1 5.29 Chikusetsusaponin IVa 
methyl ester 
C43H69O14 809.4669 809.4687 −2.2 
2 9.67 Chikusetsusaponin IV C47H75O18 927.4955 927.4953 0.2 
3 8.32 Chikusetsusaponin Ib C47H75O18 927.4983 927.4953 3.2 
4 7.90 Chikusetsusaponin IVa C42H67O14 795.4547 795.4531 2.0 
5 4.90 Notoginsenoside R4 C59H101O27 1241.6584 1241.6530 4.3 
6 6.82 Ginsenoside Rg2 C42H73O13 785.5051 785.5051 0.0 
7 7.90 Ginsenoside R0 C48H77O19 957.5109 957.5059 5.2 
8 4.48 Protopanaxadiol C30H53O4 477.3902 477.3944 −8.8 
9 3.02 Ginsenoside Rh2 C36H63O8 623.4554 623.4523 5.0 
10 2.76 Ginsenoside Rb2 C53H91O22 1079.6006 1079.6002 0.4 
11 6.82 Ginsenoside Rb1 C54H93O23 1109.6167 1109.6108 5.3 
12 3.02 Ginsenoside Rg1 C42H73O14 801.4996 801.5000 −0.5 
13 5.55 Ginsenoside Rf C42H73O14 801.5030 801.5000 3.7 
14 2.98 Ginsenoside Re C48H83O18 947.5576 947.5579 −0.3 
15 13.19 Ginsenoside Rd C48H83O18 947.5624 947.5579 4.7 
16 7.81 Chikusetsusaponin III C47H81O17 809.4669 809.4687 −2.2 
 
Figure 6: Fold changes of saponins in P. notoginseng, P. ginseng and P. japonicus. (a) the ratio of the level of 
saponins in P. notoginseng to P. ginseng; (b) the ratio of the level of saponins in P. japonicus to P. ginseng. Positive 
value means that the content of each saponin in P. notoginsng or P. japonicus was higher than in P. ginseng, 
whereas, the negative value means that the content of each saponin in P. notoginsng or P. japonicus was lower than 




This work has developed and optimized a convenient, high-throughput, and reliable UPLC-
QTOFMS method to analyze a group of saponins of P. notoginseng, P. ginseng and P. japonicus, 
which is applicable for analysis and evaluation of complex herbal medicines. This study also 
demonstrates that metabolomics analysis using UPLC-QTOFMS combined with multivariate 
statistical analysis provides some useful information in the study of Panax herbs and can be used 
as a powerful tool to profile and differentiate phytochemical compositions among different kinds 
of Panax samples. The marker compounds such as ginsenoside Rb1, Rc and chikusetsusaponin 
IVa accountable for the different metabolite profiles of P. ginseng, P. notoginseng and P. 
japonicus were observed and the results can provide a useful additional character in the 
authentication of these Panax herbs. Thus, such a UPLC-QTOF-MS-based metabolite profiling 
strategy is promising for revealing and elucidating the metabolic outcomes as a result of 
geographical variations, and genetic diversity, seasonal and different cultivation methods 
employed as well. Hence, this work is of great importance for the evaluation of overall quality of 
medicinal plants, ultimately of great significance in the pharmacological and clinical 
investigation of drug products of plant origin.  
 
ACKNOWLEDGEMENTS 
This study was financially supported by the International Collaboration Project (project number 
2006DFA02700) of the Ministry Science and Technology of the People’s Republic of China. We 




Akerele, O. (1992). WHO guidelines for the assessment of herbal medicines. Fitoterapia, 63, 
99–104.  
  
Anterola, A. M., & Lewis, N. G. (2002). Trends in lignin modification: A comprehensive 
analysis of the effects of genetic manipulations/mutations on lignification and vascular 
integrity. Phytochemistry, 61, 221–294. doi:10.1016/S0031-9422(02)00211-X. 
 
Brekhman, I., & Dardymov, I. (1969). New substances of plant origin which increase 
nonspecific resistance. Annual Review of Pharmacology, 9, 419–430. 
doi:10.1146/annurev.pa.09.040169.002223. 
 
Chan, E. C. Y., Yap, S. L., Lau, A. J., Leow, P. C., Toh, D. F., & Koh, H. L. (2007). Ultra-
performance liquid chromatography/time-of-flight mass spectrometry based 
metabolomics of raw and steamed Panax notoginseng. Rapid Communications in Mass 
Spectrometry, 21, 519–528. doi:10.1002/rcm.2864. 
 
Chang, W. T., Thissen, U., Ehlert, K. A., Koek, M. M., Jellema, R. H., Hankemeier, T., et al. 
(2006). Effects of growth conditions and processing on Rehmannia glutinosa using 
fingerprint strategy. Planta Medica, 72, 458–467. doi:10.1055/s-2005-916241. 
 
Cloarec, O., Dumas, M. E., Trygg, J., Craig, A., Barton, R. H., Lindon, J. C., et al. (2005). 
Evaluation of the orthogonal projection on latent structure model limitations caused by 
chemical shift variability and improved visualization of biomarker changes in 1H NMR 
spectroscopic metabonomic studies. Analytical Chemistry, 77, 517–526. 
doi:10.1021/ac048803i. 
 
Eisenreich, W., & Bacher, A. (2007). Advances of high-resolution NMR techniques in the 
structural and metabolic analysis of plant biochemistry. Phytochemistry, 68, 2799–2815. 
doi:10.1016/j.phytochem.2007.09.028. 
 
Farag, M. A., Huhman, D. V., Lei, Z., & Sumner, L. W. (2007). Metabolic profiling and 
systematic identification of flavonoids and isoflavonoids in roots and cell suspension 
cultures of Medicago truncatula using HPLC-UV-ESI-MS and GC-MS. Phytochemistry, 
68, 342–354. doi:10.1016/j.phytochem.2006.10.023. 
 
Fiehn, O. (2002). Metabolomics-the link between genotypes and phenotypes. Plant Molecular 
Biology, 48, 155–171. doi:10.1023/A:1013713905833. 
 
Fiehn, O., & Weckwerth, W. (2003). Deciphering metabolic networks. European Journal of 
Biochemistry, 270, 579–588. doi:10.1046/j.1432-1033.2003.03427.x. 
 
Fiehn, O., Kopka, J., Do¨rmann, P., Altmann, T., Trethewey, R. N., & Willmitzer, L. (2000). 
Metabolic profiling for plant functional genomics. Nature Biotechnology, 18, 1157–1161. 
doi:10.1038/81137. 
 
Fukusaki, E., Jumtee, K., Bamba, T., Yamaji, T., & Kobayashi, A. (2006). Metabolic 
fingerprinting and profiling of Arabidopsis thaliana leaf and its cultured cells T87 by 
GC/MS. Zeitschrift Fur Naturforschung, 61, 267–272. 
 
Gao, X. D. M., Zhao, A., Xie, G., & Jia, W. (2008). Simultaneous determination of saponins in 
flower buds of Panax notoginseng using high performance liquid chromatography. 
Biomedical Chromatography, 22, 244–249. doi:10.1002/bmc.915. 
 
Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G., & Kell, D. B. (2004). 
Metabolomics by numbers: acquiring and understanding global metabolite data. Trends 
in Biotechnology, 22, 245–252. doi:10.1016/j.tibtech.2004.03.007. 
 
Guan, J., Lai, C. M., & Li, S. P. (2007). A rapid method for the simultaneous determination of 11 
saponins in Panax notoginseng using ultra performance liquid chromatography. Journal 
of Pharmaceutical and Biomedical Analysis, 44, 996–1000. 
doi:10.1016/j.jpba.2007.03.032. 
 
Guo, Q., Yu, X. L., & Hu, X. X. (2004). Progress of chemical and pharmacological research of 
Panax japonicus. Research & Information on Traditional Chinese Medicine, 6, 17–19.  
  
Hall, R. D. (2006). Plant metabolomics: from holistic hope, to hype, to hot topic. The New 
Phytologist, 169, 453–468. doi:10.1111/j.1469-8137.2005.01632.x. 
 
Holmes, E., Tang, H. R., Wang, Y. L., & Seger, C. (2006). The assessment of plant metabolite 
profiles by NMR-based methodologies. Planta Medica, 72, 771–785. doi:10.1055/s-
2006-946682. 
 
Huhman, D. V., & Sumner, L. W. (2002). Metabolic profiling of saponins in Medicago sativa 
and Medicago truncatula using HPLC coupled to an electrospray ion-trap mass 
spectrometer. Phytochemistry, 59, 347–360. doi:10.1016/S0031-9422(01)00432-0. 
 
Jiangsu New Medical College. (1985). Dictionary of Chinese Materia Medica. Shanghai Science 
and Technology Press, Shanghai, pp. 417–420.  
  
Kevin, P. B., Jose, C. P., Mark, W., John, P. S., Kate, Y., Renata, O., et al. (2007). MSE with 
mass defect filtering for in vitro and in vivo metabolite identification. Rapid 
Communications in Mass Spectrometry, 21, 1485–1496. doi:10.1002/rcm.2996. 
 
Long, M., Millar, D. J., Kimura, Y., Donovan, G., Rees, J., Fraser, P. D., et al. (2006). 
Metabolite profiling of carotenoid and phenolic pathways in mutant and transgenic lines 
of tomato: Identification of a high antioxidant fruit line. Phytochemistry, 67, 1750–1757. 
doi:10.1016/j.phytochem.2006.02.022. 
 
Mahady, G. B., Fong, H. H. S., & Farnsworth, N. R. (2001). Botanical Dietary Supplements: 
Quality, Safety, and Efficacy. Lisse, The Netherlands: Swets & Zeitlinger Publishers, 
B.V.  
  
National Committee of Pharmacopoeia. (2005). Pharmacopoeia of the People’ s Republic of 
China (Vol. I, pp. 10). Beijing: Chemical Industry Press.  
  
Nordstrom, A., O’Maille, G., Qin, C., & Siuzdak, G. (2006). Nonlinear data alignment for 
UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and 
exogenous metabolites in human serum. Analytical Chemistry, 78, 3289–3295. 
doi:10.1021/ac060245f. 
 
Oliver, S. G., Winson, M. K., Kell, D. B., & Baganz, F. (1998). Systematic functional analysis of 
the yeast genome. Trends in Biotechnology, 16, 373–378. doi:10.1016/S0167-
7799(98)01214-1. 
 
Rochfort, S. (2005). Metabolomics reviewed: A new “omics” platform technology for systems 
biology and implications for natural products research. Journal of Natural Products, 68, 
1813–1820. doi:10.1021/np050255w. 
 
Shen, Y. F., Zhang, R., Moore, R. J., Kim, J., Metz, T. O., Hixson, K. K., et al. (2005). 
Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 
1,000–1,500 and capabilities in proteomics and metabolomics. Analytical Chemistry, 77, 
3090–3100. doi:10.1021/ac0483062. 
 
Tarachiwin, L., Ute, K., Kobayashi, A., & Fukusaki, E. (2007). 1H NMR based metabolic 
profiling in the evaluation of Japanese green tea quality. Journal of Agricultural and 
Food Chemistry, 55, 9330–9336. doi:10.1021/jf071956x. 
 
Wagner, S., Scholz, K., Donegan, M., Burton, L., Wingate, J., & Völkel, W. (2006). 
Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral 
loss scanning combined with multivariate data analysis for mercapturic acid analysis. 
Analytical Chemistry, 78, 1296–1305. doi:10.1021/ac051705s. 
 
Wang, M., Lamers, R. J. A. N., Korthout, H. A. A. J., Van Nesselrooij, J. H. J., Witkamp, R. F., 
Van Der Heijden, R., et al. (2005). Metabolomics in the context of systems biology: 
Bridging Traditional Chinese Medicine and molecular pharmacology. Phytotherapy 
Research, 19, 173–182. doi:10.1002/ptr.1624. 
 
Want, E. J., Cravatt, B. F., & Siuzdak, G. (2005). The expanding role of mass spectrometry in 
metabolite profiling and characterization. ChemBioChem, 6, 1941–1951. 
doi:10.1002/cbic.200500151. 
 
Wei, J. X., Chen, Y. G., & Du, Y. C. (1991). Introduction of separation method of dammarane-
type saponins in Panax samples. Academic Journal of Kunming Medical College, 12, 56–
64.  
  
Wilson, I. D., Nicholson, J. K., Castro-Perez, J., Granger, J. H., Johnson, K. A., Smith, B. W., 
et al. (2005). High resolution “ultra performance” liquid chromatography coupled to oa-
TOF mass spectrometry as a tool for differential metabolic pathway profiling in 
functional genomic studies. Journal of Proteome Research, 4, 591–598. 
doi:10.1021/pr049769r. 
 
Xie, G. X., Plumb, R., Su, M. M., Xu, Z. H., Zhao, A. H., Qiu, M. F., et al. (2008). Ultra-
performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. 
Journal of Separation Science, 1015–1026. doi:10.1002/jssc.200700650.  
  
Zhong, G. G., Sun, C. W., Li, Y. Y., Qi, H., Zhao, C. Y., Jiang, Y., et al. (1995). Calcium 
channel blockade and anti-free-radical actions of panaxadiol saponins Rb1, Rb2, Rb3, 
Rc, and Rd. Acta Pharmacologica Sinica, 16, 255–260. 
 
Zuo, R., Yuan, D. (2005). Research on chemical constituents and biological activities of 
Rhizoma of Panax japonicus. Lishizhen Medicine and Materia Medica Research, 16, 
838–841.  
  
 
